CN Patent

CN100490818C — β-L-2′-脱氧核苷在制备用于治疗丁型肝炎病毒感染的药物中的用途

Assigned to Novartis AG · Expires 2009-05-27 · 17y expired

What this patent protects

治疗感染丁型肝炎的宿主的方法和组合物，包括施用丁型肝炎治疗有效量的所述2’-脱氧-β-L-赤-呋喃戊糖核苷或其可药用盐或前药。

USPTO Abstract

治疗感染丁型肝炎的宿主的方法和组合物，包括施用丁型肝炎治疗有效量的所述2’-脱氧-β-L-赤-呋喃戊糖核苷或其可药用盐或前药。

Drugs covered by this patent

Patent Metadata

Patent number
CN100490818C
Jurisdiction
CN
Classification
—
Expires
2009-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.